Skip to main content

WELLS FARGO & COMPANY/MN

Position in EOLS — Evolus, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in EOLS

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$306,182
-$199,005 QoQ
Shares Held
74,497
-1.9% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Derivatives in EOLS

reported options exposure · as of Dec 31, 2020
CallValue
$277,872
CallShares
82,700
PutValue
$109,872
PutShares
32,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $924,794,490 across 59 Drug Manufacturers - Specialty & Generic names. EOLS ranks #32 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EOLS

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $306,182 74,497
2025-12-31 $505,187 75,968
2025-09-30 $295,683 48,157
2025-06-30 $385,170 41,821
2025-03-31 $592,332 49,238
2024-12-31 $544,789 49,347
2024-09-30 $564,423 34,841
2024-06-30 $254,756 23,480
2024-03-31 $210,560 15,040
2023-12-31 $141,859 13,472
2023-09-30 $127,283 13,926
2023-06-30 $423,542 58,259
2023-03-31 $97,306 11,502
2022-12-31 $42,378 5,643
2022-09-30 $39,444 4,900
2022-06-30 $97,810 8,432
2022-03-31 $203,227 18,113
2021-12-31 $181,615 27,898
2021-09-30 $463,013 60,763
2021-06-30 $253,832 20,066
2021-03-31 $175,584 13,517
2020-12-31 $187,405 55,776
2020-12-31 $277,872 82,700
2020-12-31 $109,872 32,700
2020-09-30 $106,441 27,223
2020-06-30 $237,523 44,816
2020-06-30 $79,500 15,000
2020-03-31 $233,549 56,277